- Home
- PFIS vs SLDB Comparison
PFIS vs SLDB Comparison
Compare PFIS & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFIS | SLDB |
|---|---|---|
| Founded | 1905 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.6M | 623.0M |
| IPO Year | 1998 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PFIS | SLDB |
|---|---|---|
| Price | $70.53 | $6.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $73.50 | $18.71 |
| AVG Volume (30 Days) | 43.5K | ★ 1.3M |
| Earning Date | 11-10-2026 | 11-10-2026 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | ★ 493.94 | 34.97 |
| EPS | ★ 2.95 | N/A |
| Revenue | N/A | ★ $8,094,000.00 |
| Revenue This Year | $11.65 | N/A |
| Revenue Next Year | $6.85 | N/A |
| P/E Ratio | $24.20 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $44.26 | $3.79 |
| 52 Week High | $73.37 | $11.45 |
Technical Indicators
Market Signals| Indicator | PFIS | SLDB |
|---|---|---|
| Relative Strength Index (RSI) | 54.44 | 42.00 |
| Support Level | $66.22 | $5.38 |
| Resistance Level | $73.04 | $6.77 |
| Average True Range (ATR) | 1.60 | 0.46 |
| MACD | 0.32 | 0.12 |
| Stochastic Oscillator | 65.40 | 63.64 |
Price Performance
Historical ComparisonAbout PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, equipment finance, working capital lines of credit, and construction loans, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.